ROCK2 Polymorphism and Expression Contribute to Increased Susceptibility and Poor Prognosis in Hepatocellular Carcinoma

References

• Kulik L, El-Serag H. Epidemiology and management of hepatocellular carcinoma. Gastroenterology. 2019;156(2):477–491. doi:10.1053/j.gastro.2018.08.065
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. Ca Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.21338
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. doi:10.3322/caac.21590
   PubMed Web of Science ®Google Scholar
• Liu J, Liu M. Research progress on relevant diseases of RhoA/ROCK signaling pathway. J Hainan Med Coll. 2019;25(06):78–82. doi:10.13210/j.cnki.jhmu.20190129.002
   Google Scholar
• Hua Y, Wang K, He J, et al. Overexpression of rho-associated coiled-coil containing protein kinase 2 is correlated with clinical progression and poor prognosis in breast cancer. Med Sci Mon. 2018;24:4776–4781. doi:10.12659/MSM.908507
   PubMed Web of Science ®Google Scholar
• Luo J, Lou Z, Zheng J. Targeted regulation by ROCK2 on bladder carcinoma via Wnt signaling under hypoxia. Cancer Biomark. 2019;24(1):109–116. doi:10.3233/CBM-181949
   PubMed Web of Science ®Google Scholar
• Pranatharthi A, Thomas P, Udayashankar AH, Bhavani C, Srivastava S. RhoC regulates radioresistance via crosstalk of ROCK2 with the DNA repair machinery in cervical cancer. J Exp Clin Cancer Res. 2019;38(1):392. doi:10.1186/s13046-019-1385-7
   PubMed Web of Science ®Google Scholar
• Zhou J, Sun H, Wang Z, Cong W, Fan J. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (2019 edition). Liver Cancer. 2020;9(6):682–720. doi:10.1159/000509424
   PubMed Web of Science ®Google Scholar
• Fukui H, Saito H, Ueno Y, et al. Evidence-based clinical practice guidelines for liver cirrhosis 2015. J Gastroenterol. 2016;51(7):629–650. doi:10.1007/s00535-016-1216-y
   PubMed Web of Science ®Google Scholar
• Hou J, Wang G, Wang F, et al. Guideline of prevention and treatment for chronic hepatitis B (2015 update). J Clin Transl Hepatol. 2017;5(4):297–318. doi:10.14218/JCTH.2016.00019
   PubMed Web of Science ®Google Scholar
• Forner A, Reig ME, Lope CRD, Bruix J. Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis. 2010;30(1):61–74. doi:10.1055/s-0030-1247133
   PubMed Web of Science ®Google Scholar
• Qin L, Qin J, Zhen X, Qian Y, Huang L. Curcumin protects against hepatic stellate cells activation and migration by inhibiting the CXCL12/CXCR4 biological axis in liver fibrosis: a study in vitro and in vivo. Biomed Pharmacother. 2018;101:599–607. doi:10.1016/j.biopha.2018.02.091
   PubMed Web of Science ®Google Scholar
• Qin L, Qin J, Lv X, Yin C, Zhang J. MIF promoter polymorphism increases peripheral blood expression levels, contributing to increased susceptibility and poor prognosis in hepatocellular carcinoma. Oncol Lett. 2021;22(1):549. doi:10.3892/ol.2021.12810
   PubMed Web of Science ®Google Scholar
• Julian L, Olson MF. Rho-associated coiled-coil containing kinases (ROCK) structure, regulation, and functions. Small GTPases. 2014;5:e29846. doi:10.4161/sgtp.29846
   PubMedGoogle Scholar
• Pan P, Shen M, Yu H, Li Y, Hou T. Advances in the development of Rho-associated protein kinase (ROCK) inhibitors. Drug Discov Today. 2013;18(23–24):1323–1333. doi:10.1016/j.drudis.2013.09.010
   PubMed Web of Science ®Google Scholar
• Pelosi M, Marampon F, Zani BM, Prudente S, Rosenthal N. ROCK2 and its alternatively spliced isoform ROCK2m positively control the maturation of the myogenic program. Mol Cell Biol. 2007;27(17):6163–6176. doi:10.1128/MCB.01735-06
   PubMed Web of Science ®Google Scholar
• Chen W, Mao K, Liu Z, Dinh-Xuan A. The role of the RhoA/Rho kinase pathway in angiogenesis and its potential value in prostate cancer (Review). Oncol Lett. 2014;8(5):1907–1911. doi:10.3892/ol.2014.2471
   PubMed Web of Science ®Google Scholar
• Inaba N, Ishizawa S, Kimura M, Fujioka K, Manome Y. Effect of inhibition of the ROCK isoform on RT2 malignant glioma cells. Anticancer Res. 2010;30(9):3509–3514. doi:10.1097/CAD.0b013e32833d19f0
   PubMed Web of Science ®Google Scholar
• Jeong KJ, Park SY, Cho KH, et al. The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion. Oncogene. 2012;31(39):4279–4289. doi:10.1038/onc.2011.595
   PubMed Web of Science ®Google Scholar
• Jiang L, Liu X, Kolokythas A, et al. Downregulation of the Rho GTPase signaling pathway is involved in the microRNA-138-mediated inhibition of cell migration and invasion in tongue squamous cell carcinoma. Int J Cancer. 2010;127(3):505–512. doi:10.1002/ijc.25320
   PubMed Web of Science ®Google Scholar
• Kale VP, Hengst JA, Desai DH, et al. A novel selective multikinase inhibitor of ROCK and MRCK effectively blocks cancer cell migration and invasion. Cancer Lett. 2014;354(2):299–310. doi:10.1016/j.canlet.2014.08.032
   PubMed Web of Science ®Google Scholar
• Lane J, Martin TA, Watkins G, Mansel RE, Jiang WG. The expression and prognostic value of ROCK I and ROCK II and their role in human breast cancer. Int J Oncol. 2008;33(3):585–593. doi:10.1002/app.11859
   PubMed Web of Science ®Google Scholar
• Wong CCL, Wong CM, Tung EKK, Man K, Ng IOL. Rho-kinase 2 is frequently overexpressed in hepatocellular carcinoma and involved in tumor invasion. Hepatology. 2010;49(5):1583–1594. doi:10.1002/hep.22836
   Web of Science ®Google Scholar
• Huang D, Du X, Yuan R, Chen L, Liu T. Rock2 promotes the invasion and metastasis of hepatocellular carcinoma by modifying MMP2 ubiquitination and degradation. Biochem Biophys Res Commun. 2014;453(1):49–56. doi:10.1016/j.bbrc.2014.09.061
   PubMed Web of Science ®Google Scholar
• Li G, Liu T, Yu X, et al. Protective effect and regulation mechanism of Rock2 on ultraviolet-induced DNA damage in liver cancer cells. China Oncol. 2012;22(7):505–509. doi:10.3969/j.issn.1007-3969.2012.07.005
   Google Scholar
• Du Y, Lu S, Ge J, Long D, Zhou W. ROCK2 disturbs MKP1 expression to promote invasion and metastasis in hepatocellular carcinoma. Am J Cancer Res. 2020;10(3):884–896.
   PubMed Web of Science ®Google Scholar
• Niu Y, Tang G. miR-185-5p targets ROCK2 and inhibits cell migration and invasion of hepatocellular carcinoma. Oncol Lett. 2019;17(6):5087–5093. doi:10.3892/ol.2019.10144
   PubMed Web of Science ®Google Scholar
• Zucman-Rossi J, Villanueva A, Nault JC, Llovet JM. Genetic landscape and biomarkers of hepatocellular carcinoma. Gastroenterology. 2015;149:1226–1239. doi:10.1053/j.gastro.2015.05.061
   PubMed Web of Science ®Google Scholar
• Seasholtz TM, Wessel J, Rao F, et al. Rho kinase polymorphism influences blood pressure and systemic vascular resistance in human twins: role of heredity. Hypertension. 2006;47(5):937–947. doi:10.1161/01.HYP.0000217364.45622.f0
   PubMed Web of Science ®Google Scholar
• Kalender ME, Demiryürek S, Oztuzcu S, et al. Association between the Thr431Asn polymorphism of the ROCK2 gene and risk of developing metastases of breast cancer. Oncol Res. 2010;18(11):583–591. doi:10.3727/096504010X12767359113767
   PubMed Web of Science ®Google Scholar
• Sari I, Berberoglu B, Ozkara E, Oztuzcu S, Demiryurek AT. Role of Rho-kinase gene polymorphisms and protein expressions in colorectal cancer development. Pathobiology. 2013;80(3):138–145. doi:10.1159/000341395
   PubMed Web of Science ®Google Scholar
• Açık DY, Yılmaz M, Sarı İ, Öztuzcu S, Sayıner ZA. Investigation of Rho-kinase expressions and polymorphisms in mantle cell lymphoma patients. Turk J Haematol. 2016;33(2):141–147. doi:10.4274/tjh.2015.0193
   PubMed Web of Science ®Google Scholar